Birbirinden Bağımsız İki Malignite Sonrası B-All Gelişen Olgu

Terwilliger T, Abdul-Hay M. Acute lymphoblastic leukemia: a comprehensive review and 2017 update. Blood cancer journal. 2017;7(6):e577.

Malard F, Mohty M. Acute lymphoblastic leukaemia. Lancet (London, England). 2020;395(10230):1146-62.

Kayser S, Döhner K, Krauter J, Köhne CH, Horst HA, Held G, et al. The impact of therapy-related acute myeloid leukemia (AML) on outcome in 2853 adult patients with newly diagnosed AML. Blood. 2011;117(7):2137-45.

Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127(20):2391-405.

Leone G, Mele L, Pulsoni A, Equitani F, Pagano L. The incidence of secondary leukemias. Haematologica. 1999;84(10):937-45.

Asif H, Ahmad U, Ahmad N, Tahir A, Bokhari SW, Ahsan B. Therapy-Related B-cell Acute Lymphoblastic Leukemia: A Case Series and Literature Review. Cureus. 2025;17(2):e79664.

Ribera JM. Therapy-related acute lymphoblastic leukemia. Haematologica. 2018;103(10):1581-3.

Saygin C, Kishtagari A, Cassaday RD, Reizine N, Yurkiewicz I, Liedtke M, et al. Therapy-related acute lymphoblastic leukemia is a distinct entity with adverse genetic features and clinical outcomes. Blood advances. 2019;3(24):4228-37.

Giri S, Chi M, Johnson B, McCormick D, Jamy O, Bhatt VR, et al. Secondary acute lymphoblastic leukemia is an independent predictor of poor prognosis. Leukemia research. 2015;39(12):1342-6.

Hu T, Shen J, Liu W, Zheng Z. Multiple myeloma secondary to acute lymphoblastic leukemia: A case report. Medicine. 2019;98(1):e14018.

Aldoss I, Capelletti M, Park J, Pistofidis RS, Pillai R, Stiller T, et al. Acute lymphoblastic leukemia as a clonally unrelated second primary malignancy after multiple myeloma. Leukemia. 2019;33(1):266-70.

Castillo JJ, Gertz MA. Secondary malignancies in patients with multiple myeloma, Waldenström macroglobulinemia and monoclonal gammopathy of undetermined significance. Leukemia & lymphoma. 2017;58(4):773-80.

Bergsagel DE, Bailey AJ, Langley GR, MacDonald RN, White DF, Miller AB. The chemotherapy of plasma-cell myeloma and the incidence of acute leukemia. The New England journal of medicine. 1979;301(14):743-8.

Davies SM. Therapy-related leukemia associated with alkylating agents. Medical and pediatric oncology. 2001;36(5):536-40.

Haase D, Hanf V, Schulz T. [Therapy-related hematologic neoplasias after breast cancer. Epidemiologic, etiologic and cytogenetic aspects and new risk factors according to published data and own results]. Medizinische Klinik (Munich, Germany : 1983). 2004;99(9):506-17.

Swaika A, Frank RD, Yang D, Finn LE, Jiang L, Advani P, et al. Second primary acute lymphoblastic leukemia in adults: a SEER analysis of incidence and outcomes. Cancer medicine. 2018;7(2):499-507.

Kröger N, Damon L, Zander AR, Wandt H, Derigs G, Ferrante P, et al. Secondary acute leukemia following mitoxantrone-based high-dose chemotherapy for primary breast cancer patients. Bone marrow transplantation. 2003;32(12):1153-7.

Kaplan HG, Malmgren JA, Atwood M. Leukemia incidence following primary breast carcinoma treatment. Cancer. 2004;101(7):1529-36.

Mei J, Na L, Dexiang J, Fei L, Zhanglin Z. Acute B Lymphoblastic Leukemia Developing in Patients with Multiple Myeloma: Presentation of Two Cases. Turkish journal of haematology : official journal of Turkish Society of Haematology. 2019;36(4):287-9.

Lau LG, Tan LK, Koay ES, Liu TC. Acute lymphoblastic leukemia after tandem autologous stem cell transplantations for multiple myeloma. Leukemia. 2005;19(2):299-301.

Hawkins MM, Wilson LM, Stovall MA, Marsden HB, Potok MH, Kingston JE, et al. Epipodophyllotoxins, alkylating agents, and radiation and risk of secondary leukaemia after childhood cancer. BMJ (Clinical research ed). 1992;304(6832):951-8.

Smith SM, Le Beau MM, Huo D, Karrison T, Sobecks RM, Anastasi J, et al. Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series. Blood. 2003;102(1):43-52.

He G, Wu D, Sun A, Xue Y, Jin Z, Qiu H, et al. B-Lymphoid and myeloid lineages biphenotypic acute leukemia with t(8;21)(q22;q22). International journal of hematology. 2008;87(2):132-6.